Innovent Biologics, the first Chinese firm to gain approval for a GLP-1 weight loss and diabetes drug, has partnered with JD ...

CVS Caremark will stop covering Eli Lilly’s Zepbound. Wegovy, the GLP-1 medication to treat obesity from Lilly competitor ...

Weight loss drugs have become quite popular in the past years. However, there are a few aspects of the drug that need to be explored more. One such aspect is its effect on postmenopausal women.

Ongoing research is needed to fully understand their risks, especially for long-term and higher-dose users. However, many ...

I am a 75-year-old woman who isn’t prediabetic or diabetic. My BMI is 31.2. My doctor has prescribed a trial of metformin for ...

Novo Nordisk is in the lead, but not alone. Obesity doctors say they are gearing up for demand, predicted to be high. Some ...

Ozempic has gained a lot of popularity with many referring to it as the miracle weight loss drug However how much do you ...

US-based consumer insights company 1Q has launched a prescription-verified panel of users of GLP-1 drugs, including weight ...

Around 1.5 million people in the UK are thought to be using weight loss jabs, with many paying privately as NHS supplies ...

Weight loss injections are now available on the NHS but experts warn thousands of patients may be vulnerable to serious side ...